Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer
Titel:
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer
Auteur:
Venturini, M. Bighin, C. Monfardini, S. Cappuzzo, F. Olmeo, N. Durando, A. Puglisi, F. Nicoletto, O. Lambiase, A. Mastro, L. Del
Verschenen in:
Breast cancer research and treatment
Paginering:
Jaargang 95 (2005) nr. 1 pagina's 45-53
Jaar:
2005
Inhoud:
Uitgever:
Kluwer Academic Publishers-Plenum Publishers, New York